OCPNY Stock Performance, Insider Transaction and News

OCPNY - OLYMPUS CORPORATION ADR-EACH CN

Market Cap	23.02B	P/E	23.68	EPS this Y	-	Ern Qtrly Grth	-
Income	126.85B	Forward P/E	18.18	EPS next Y	-	50D Avg Chg	-4.00%
Sales	925.86B	PEG	-	EPS past 5Y	43.73%	200D Avg Chg	-12.00%
Dividend	78.00%	Price/Book	0.04	EPS next 5Y	7.20%	52W High Chg	-76.00%
Recommedations	-	Quick Ratio	1.29	Shares Outstanding	1.27B	52W Low Chg	7.00%
Insider Own	-	ROA	8.15%	Shares Float	1.24B	Beta	0.68
Inst Own	0.04%	ROE	23.29%	Shares Shorted/Prior	-/-	Price	18.00
Gross Margin	65.66%	Profit Margin	12.98%	Avg. Volume	493,725	Target Price	23.60
Oper. Margin	18.81%	Earnings Date	-	Volume	465	Change	0.00%

Healthcare | Medical Instruments & Supplies | Japan

About OLYMPUS CORPORATION ADR-EACH CN

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy system, surgical microscopes, endoscope reprocessors, operating rooms, repair and maintenance services. The Therapeutic Solutions Business segment provides urology, gynecology, respiratory, ear, nose, and throat products; GI endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Tokyo, Japan.

OCPNY Chatroom

DavidKozin Posted - 02/25/15

FDA issues alert re: ERCP endoscopes (Major Supplier: $OCPNY $FUJIY) associated with "superbug" fast-track new lables http://stks.co/j1qpt

ycharts Posted - 06/16/14

Bloody Disruption: New Threat to Quest, LabCorp $LH $DGX $WBA $UNH $SIEGY $OCPNY

valuewalk Posted - 10 years ago

Olympus' Former Executives Get Suspended Sentence In Fraud Case http://stks.co/gblm $OCPNY

jimintokyo Posted - 11 years ago

$OCPNY $SNE Sony Olympus medical joint venture - good synergy / post-Woodford scandal http://stks.co/hQir

Benzinga Posted - 11/14/12

$AAPL $NJ $OCPNY $SNE Sony to Fund Image Sensor Business with Convertible Bond: http://stks.co/cEHi

bradloncar Posted - 03/11/12

Japan uswd to be so well known for their business ethics. Then in 1 yr you've had the TEPCO and $OCPNY debacles. What in the world happened.

bradloncar Posted - 02/13/12

I don't even understand why $OCPNY is waiting to install new management before they sell the company. They should just sell it.

STtech Posted - 01/23/12

Olympus In Final Stages Of Negotiations To Partner With Sony http://stks.co/22Y2 via Tech Crunch $OCPNY $SNE

STtech Posted - 01/19/12

Fujifilm Reaches Out to Rival http://stks.co/1zqQ via WSJ $FUJIY $OCPNY

STtech Posted - 01/12/12

Samsung may consider alliance with Olympus http://stks.co/1txS via Reuters $OCPNY

tomj Posted - 12/15/11

A corporate secretary's governance wish list http://stks.co/1Z2a $MFGLQ $OCPNY

jimintokyo Posted - 11/18/11

Ex-CEO Woodford to speak in Tokyo Fri Nov 25th http://stks.co/1COY $OCPNY

55j Posted - 11/11/11

$ocpny the finacial disclosure is for protect investors. window-dressing is not for protect investors. for whom delisting is?

tomj Posted - 11/09/11

Olympus: something was wrong after all http://stks.co/12vp $OCPNY

BullTard Posted - 11/08/11

Interested in hearing any comments on $OCPNY. The company is selling well below book val. Has a dominant medical division that has value.

Stocktwits Posted - 11/08/11

We've Added a StockTwits Olympus Corp Stream Ticker $OCPNY to Discuss The Current "Situation" http://stks.co/11v3 ht @BullTard